Intactis Bio Corp.
PrivateLast Round
Grant
Jul 16, 2026
Total Funding Raised
$350,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Intactis Bio Corp. is a biotechnology and computing company that develops biohybrid processing units using 3D-printed living neural tissue for energy-efficient artificial intelligence and machine learning computation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Usage-Based SaaS, Freemium
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intactis Bio Corp. Comparables
Compare Intactis Bio Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Biological Computing Co. | 45% | |
| PearCode | 37% | |
| Twist Bioscience Corporation | 35% | |
Intactis Bio Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2026 | ||||
| Pre Seed | Mar 26, 2026 | ||||
| Seed | Sep 26, 2025 |
Key People
Founding team and executive leadership
Intactis Bio Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Utah Innovation Fund | Pre Seed |
| Shift Grants | Grant |
| Altitude Lab | Grant |
| rpv | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
Received grant funding from Altitude Lab, deepfunding, and others.
- Mar 26, 2026
$350K round with participation from rpv and Utah Innovation Fund.
Intactis Bio Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intactis Bio Corp.'s valuation, stock price, and market status.